Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
March 28, 2025
Evofem Improves Phexxi® Patient Experiences Through New Agreement with VitaCare Prescription Services
April 27, 2022
Related Post
-
-
Upcoming Aditxt Weekly Update to Highlight Pearsanta’s Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer Detection
March 28, 2025
-
Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk
March 24, 2025
-
PharmAla Contracts with Partner to Act as US Distributor
March 24, 2025